{"id":810414,"date":"2025-02-07T07:33:38","date_gmt":"2025-02-07T12:33:38","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\/"},"modified":"2025-02-07T07:33:38","modified_gmt":"2025-02-07T12:33:38","slug":"matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\/","title":{"rendered":"Matinas BioPharma Appoints Evelyn D\u2019An to Board of Directors as Audit Committee Chair"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">BEDMINSTER, N.J., Feb.  07, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CeYIGvcr-VTaJGZPiYtTuB_j0lbAbjjQ4PckirDNuUwt8STdRp8OP-DFsUEu9iFs2672b4lxsiGNutBVBuVhrKQXizfP-CYeqNKipdnwa6g=\" rel=\"nofollow\" target=\"_blank\">Matinas BioPharma<\/a> Holdings, Inc. (NYSE American: MTNB) today announced the appointment of Evelyn D\u2019An to its Board of Directors as an independent director and Chair of the Audit Committee, effective Wednesday, February 5, 2025.<\/p>\n<p align=\"justify\">Ms. D\u2019An is an experienced board director and financial leader with extensive corporate governance, financial oversight, and accounting experience with a range of both public and private companies, where she has served as Chair of Audit Committees and as a member of various other board committees. Ms. D\u2019An is also a former partner of Ernst &amp; Young, where she spent 18 years serving clients in retail, consumer products, technology, and other sectors. She will serve as Chair of the Matinas Audit Committee and will also serve as a member of the Matinas Nominating &amp; Governance Committee.<\/p>\n<p align=\"justify\">\u201cWe are delighted to welcome Evelyn to the Matinas Board,\u201d commented Jerome D. Jabbour, Chief Executive Officer of Matinas. \u201cEvelyn\u2019s background as an experienced Audit Committee chair and business leader fills a need, and her commercial and strategic expertise complements the experience of our other Board members. We are honored that she has chosen to join us at this important time for the Company.\u201d<\/p>\n<p align=\"justify\">\n        <strong>About Matinas BioPharma<\/strong>\n      <\/p>\n<p align=\"justify\">Matinas BioPharma is a biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology.<\/p>\n<p align=\"justify\">For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=llaf-GVc0vAYwMDiM1MpfNDNvS1ccux8Jje_H-wjwrrDscAd40YYG4I_gHYoLD9QSSgGY-G64zhrDK9NN7PhJVHioZXV7Hp6R52Sywmhjq0=\" rel=\"nofollow\" target=\"_blank\">www.matinasbiopharma.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Forward-looking Statements <\/strong>\n      <\/p>\n<p align=\"justify\">This release contains &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995, including those relating to the appointment of Ms. D\u2019An, and other statements that are predictive in nature, that depend upon or refer to future events or conditions. All statements other than statements of historical fact are statements that could be forward-looking statements. Forward-looking statements include words such as &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;could,&#8221; &#8220;believes,&#8221; &#8220;estimates&#8221; and similar expressions. These statements involve known and unknown risks, uncertainties and other factors which may cause actual results to be materially different from any future results expressed or implied by the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, including, but not limited to, the sale of MAT 2203, and the evaluation of other alternatives for the Company, including a winddown or dissolution of the Company; and the other factors listed under &#8220;Risk Factors&#8221; in our filings with the SEC, including Forms 10-K, 10-Q and 8-K. Investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this release. Except as may be required by law, the Company does not undertake any obligation to release publicly any revisions to such forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Matinas BioPharma\u2019s product candidates are all in a development stage and are not available for sale or use.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NDU5NiM2NzQwMTk4IzIwMjM2MTg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/Yjk0YmZjYzYtZGM0Zi00NGY1LWFlZDUtYjg4MWY3ZjNhZDBkLTEwMzUxODY=\/tiny\/Matinas-BioPharma-Holdings-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Investor Contact\r\nJerome D. Jabbour\r\nChief Executive Officer\r\n(908) 484-8805\r\noperations@matinasbiopharma.com<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BEDMINSTER, N.J., Feb. 07, 2025 (GLOBE NEWSWIRE) &#8212; Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of Evelyn D\u2019An to its Board of Directors as an independent director and Chair of the Audit Committee, effective Wednesday, February 5, 2025. Ms. D\u2019An is an experienced board director and financial leader with extensive corporate governance, financial oversight, and accounting experience with a range of both public and private companies, where she has served as Chair of Audit Committees and as a member of various other board committees. Ms. D\u2019An is also a former partner of Ernst &amp; Young, where she spent 18 years serving clients in retail, consumer products, technology, and other sectors. She will serve as Chair of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Matinas BioPharma Appoints Evelyn D\u2019An to Board of Directors as Audit Committee Chair&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-810414","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Matinas BioPharma Appoints Evelyn D\u2019An to Board of Directors as Audit Committee Chair - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Matinas BioPharma Appoints Evelyn D\u2019An to Board of Directors as Audit Committee Chair - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BEDMINSTER, N.J., Feb. 07, 2025 (GLOBE NEWSWIRE) &#8212; Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of Evelyn D\u2019An to its Board of Directors as an independent director and Chair of the Audit Committee, effective Wednesday, February 5, 2025. Ms. D\u2019An is an experienced board director and financial leader with extensive corporate governance, financial oversight, and accounting experience with a range of both public and private companies, where she has served as Chair of Audit Committees and as a member of various other board committees. Ms. D\u2019An is also a former partner of Ernst &amp; Young, where she spent 18 years serving clients in retail, consumer products, technology, and other sectors. She will serve as Chair of &hellip; Continue reading &quot;Matinas BioPharma Appoints Evelyn D\u2019An to Board of Directors as Audit Committee Chair&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-07T12:33:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NDU5NiM2NzQwMTk4IzIwMjM2MTg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Matinas BioPharma Appoints Evelyn D\u2019An to Board of Directors as Audit Committee Chair\",\"datePublished\":\"2025-02-07T12:33:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\\\/\"},\"wordCount\":492,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1NDU5NiM2NzQwMTk4IzIwMjM2MTg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\\\/\",\"name\":\"Matinas BioPharma Appoints Evelyn D\u2019An to Board of Directors as Audit Committee Chair - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1NDU5NiM2NzQwMTk4IzIwMjM2MTg=\",\"datePublished\":\"2025-02-07T12:33:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1NDU5NiM2NzQwMTk4IzIwMjM2MTg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1NDU5NiM2NzQwMTk4IzIwMjM2MTg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Matinas BioPharma Appoints Evelyn D\u2019An to Board of Directors as Audit Committee Chair\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Matinas BioPharma Appoints Evelyn D\u2019An to Board of Directors as Audit Committee Chair - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\/","og_locale":"en_US","og_type":"article","og_title":"Matinas BioPharma Appoints Evelyn D\u2019An to Board of Directors as Audit Committee Chair - Market Newsdesk","og_description":"BEDMINSTER, N.J., Feb. 07, 2025 (GLOBE NEWSWIRE) &#8212; Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of Evelyn D\u2019An to its Board of Directors as an independent director and Chair of the Audit Committee, effective Wednesday, February 5, 2025. Ms. D\u2019An is an experienced board director and financial leader with extensive corporate governance, financial oversight, and accounting experience with a range of both public and private companies, where she has served as Chair of Audit Committees and as a member of various other board committees. Ms. D\u2019An is also a former partner of Ernst &amp; Young, where she spent 18 years serving clients in retail, consumer products, technology, and other sectors. She will serve as Chair of &hellip; Continue reading \"Matinas BioPharma Appoints Evelyn D\u2019An to Board of Directors as Audit Committee Chair\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-07T12:33:38+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NDU5NiM2NzQwMTk4IzIwMjM2MTg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Matinas BioPharma Appoints Evelyn D\u2019An to Board of Directors as Audit Committee Chair","datePublished":"2025-02-07T12:33:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\/"},"wordCount":492,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NDU5NiM2NzQwMTk4IzIwMjM2MTg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\/","name":"Matinas BioPharma Appoints Evelyn D\u2019An to Board of Directors as Audit Committee Chair - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NDU5NiM2NzQwMTk4IzIwMjM2MTg=","datePublished":"2025-02-07T12:33:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NDU5NiM2NzQwMTk4IzIwMjM2MTg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NDU5NiM2NzQwMTk4IzIwMjM2MTg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/matinas-biopharma-appoints-evelyn-dan-to-board-of-directors-as-audit-committee-chair\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Matinas BioPharma Appoints Evelyn D\u2019An to Board of Directors as Audit Committee Chair"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/810414","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=810414"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/810414\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=810414"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=810414"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=810414"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}